Erratum: The novel oral drug subetta exerts an antidiabetic effect in the diabetic goto-kakizaki rat: Comparison with rosiglitazone (Journal of Diabetes Research (2013) 2013 (763125) DOI: 10.1155/2013/763125);The novel oral drug subetta exerts an antidiabetic effect in the diabetic goto-kakizaki Rat: Comparison with rosiglitazone

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Bailbé, Danielle ^a   Philippe, Erwann ^a   Gorbunov, Evgeniy ^b   Tarasov, Sergey ^b   Epstein, Oleg ^b   Portha, Bernard ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b OOO NPF Materia Medica Holding   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBUNIT BETA; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SUBETTA; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIBODY; ANTIDIABETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE BLOOD LEVEL; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GOTO KAKIZAKI RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT RESPONSE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; DRUG ANTAGONISM; DRUG EFFECT; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; ANTIBODIES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RECEPTOR, INSULIN; THIAZOLIDINEDIONES;

EID: 84878700377     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2019/2938413     Document Type: Erratum

References (42)

1. Epstein O. I., Ultra-Low Doses (History of One Study) 2008 Moscow, Russia Publishing House of RAMN
2. Epstein O. I., Possible mechanisms of action of potentiated drugs and some of the questions of functioning of biosystems Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences 1999 1 132 149
3. Epstein O. I., Release-activity: a long way from the phenomenon to new drugs. Bulletin of Experimental Biology and Medicine 2012 154 54 58
4. Chu X., Zhavbert E. S., Dugina J. L., Effects of chronic treatment with the eNOS stimulator Impaza on penis length and sexual behaviors in rats with a high baseline of sexual activity. International Journal of Impotence Research 2013 10.1038/ijir.2013.12
5. Nicoll J., Gorbunov E., Tarasov S., Epstein O. I., Subetta treatment increases adiponectin secretion by mature human adipocytes in vitro. International Journal of Endocrinology 2013 2013 4 925874 10.1155/2013/925874
6. Tarasov S. A., Zarubaev V. V., Gorbunov E. A., Sergeeva S. A., Epstein O. I., Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A, (H1N1) 2009 virus infection in mice. Antiviral Research 2012 93 219 224 10.1016/j.antiviral.2011.11.018
7. Kheyfets I. A., Spasov A. A., Voronkova M. P., Dugina J. L., Epstein O. I., Study of antidiabetic activity of subetta and Rosiglitazone on the model of streptozotocin diabetes in rats. Bulletin of Experimental Biology and Medicine 2012 153 54 56 10.1007/s10517-012-1641-8
8. Sizova L. V., Treatment of early arthritis using arthrofoon (ultra-low doses of antibodies to tumor necrosis factor- α). Indian Journal of Pharmacology 2011 43 724 725
9. Lisachev P. D., Shtark M. B., Sokolova O. O., Pustylnyak V. O., Salakhutdinova M. Y., Epstein O. I., A comparison of the dynamics of S100B, S100A1, and S100A6 mRNA expression in Hippocampal CA1 area of rats during long-term potentiation and after low-frequency stimulation. Cardiovascular Psychiatry and Neurology 2010 2010 6 2-s2.0-77958514660 10.1155/2010/720958 720958
10. Andrianov V. V., Epstein O. I., Gainutdinova T. K., Shtark M. B., Timoshenko A. K., Gainutdinov K. L., Antibodies to calcium-binding S100B protein block the conditioning of long-term sensitization in the terrestrial snail. Pharmacology Biochemistry and Behavior 2009 94 1 37 42 2-s2.0-70349207049 10.1016/j.pbb.2009.07.003
11. Castagne V., Lemaire M., Kheyfets I., Dugina J. L., Sergeeva S. A., Epstein O. I., Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat. Journal of Pharmacy and Pharmacology 2008 60 3 309 316 2-s2.0-39449085936 10.1211/jpp.60.3.0005 (Pubitemid 351269817)
12. Chu X., Ågmo A., Sexual incentive motivation in old male rats: the effects of sildenafil and a compound (Impaza) stimulating endothelial NO synthase. Pharmacology Biochemistry and Behavior 2008 89 2 209 217 2-s2.0-39149116358 10.1016/j.pbb.2007.12.012
13. Chu X., Zhavbert E. S., Dugina J. L., Kheyfets I. A., Sergeeva S. A., Epstein O. I., Ågmo A., Sildenafil and a compound stimulating endothelial NO synthase modify sexual incentive motivation and copulatory behavior in male wistar and fisher 344 rats. Journal of Sexual Medicine 2008 5 9 2085 2099 2-s2.0-51349119283 10.1111/j.1743-6109.2008.00937.x
14. Epstein O. I., Introducing a new class of pharmaceuticals. Pharmaceutical Executive 2007 27 S14
15. Kalueff A. V., Antibodies to S-100 protein in anxiety-depressive disorders in experimental and clinical conditions. Animal Models in Biological Psychiatry 2006 New York, NY, USA Nova Science
16. Dugina J. L., Petrov V. I., Babayeva A. R., Martyushev-Poklad A. V., Tcherevkova E. V., Epstein O. I., Sergeeva S. A., A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor- α and diclofenac in rheumatoid arthritis. International Journal of Tissue Reactions 2005 27 1 15 21 2-s2.0-15944411666 (Pubitemid 40439615)
17. Epstein O. I., Beregovoy N. A., Sorokina N. S., Starostina M. V., Shtark M. B., Gainutdinov K. L., Gainutdinova T. K., Muhamedshina D. I., Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrations. Frontiers in Bioscience 2003 8 A79 A84 2-s2.0-1542463982 (Pubitemid 39069946)
18. Karpova G. V., Fomina T. I., Vetoshkina T. V., Dubskaya T. Y., Voronova O. L., Timina E. A., Abramova E. V., Ermolaeva L. A., Perova A. V., Preclinical studie of general toxic properties of preparations containing ultralow doses of antibodies to endogenous regulators. Bulletin of Experimental Biology and Medicine 2009 148 3 543 546 2-s2.0-77649188648 10.1007/s10517-010-0760-3
19. Portha B., Giroix M. H., Serradas P., Gangnerau M. N., Movassat J., Rajas F., Bailbe D., Plachot C., Mithieux G., Marie J. C., β -cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony. Diabetes 2001 50 1 S89 S93 2-s2.0-0035129014 (Pubitemid 32148227)
20. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Van Cauter E., Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. The New England Journal of Medicine 1988 318 19 1231 1239 2-s2.0-0023916553
21. Taylor S. I., Accili D., Imai Y., Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 1994 43 6 735 740 2-s2.0-0028229508
22. Portha B., Programmed disorders of β -cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes/Metabolism Research and Reviews 2005 21 6 495 504 2-s2.0-27844486109 10.1002/dmrr.566 (Pubitemid 41646009)
23. Portha B., Giroix M. H., Tourrel-Cuzin C., Le-Stunff H., Movassat J., Joost H. G., Schürmann A., Al-Hasani H., The GK rat: a prototype for the study of non-overweight type 2 diabetes? Animal Models of Diabetes Research 2012 New-York, NY, USA Humana Press
24. Yasuda N., Inoue T., Nagakura T., Yamazaki K., Kira K., Saeki T., Tanaka I., Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats. Journal of Pharmacology and Experimental Therapeutics 2004 310 2 614 619 2-s2.0-3342908639 10.1124/jpet.103.064964 (Pubitemid 38988906)
25. Dunmore S. J., Brown J. E., The role of adipokines in β -cell failure of type 2 diabetes. Journal of Endocrinology 2013 216 T37 T45
26. Mazo E. B., Gamidov S., Ovchinnikov R. I., Viagra, cialis, impase-which of them, to whom, when and how? Urologiia 2004 5 42 48 2-s2.0-21644476629
27. Youngren J. F., Regulation of insulin receptor function. Cellular and Molecular Life Sciences 2007 64 7-8 873 891 2-s2.0-34247140171 10.1007/s00018-007-6359-9 (Pubitemid 46597750)
28. Shehzad A., Iqbal W., Shehzad O., Lee Y. S., Adiponectin: regulation of its production and its role in human diseases. Hormones 2012 11 1 8 20
29. Zhang B., Salituro G., Szalkowski D., Li Z., Zhang Y., Royo I., Vilella D., Díez M. T., Pelaez F., Ruby C., Kendall R. L., Mao X., Griffin P., Calaycay J., Zierath J. R., Heck J. V., Smith R. G., Moller D. E., Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 1999 284 5416 974 977 2-s2.0-0033532347 10.1126/science.284.5416.974 (Pubitemid 29288438)
30. Luo R., Li X., Jiang R., Gao X., Lü Z., Hua W., Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance. Journal of International Medical Research 2012 40 621 630
31. Stumvoll M., Goldstein B. J., van Haeften T. W., Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 2005 365 9467 1333 1346 2-s2.0-17044386953 10.1016/S0140-6736(05)61032-X
32. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937 (Pubitemid 44453463)
33. Srinivasan K., Patole P. S., Kaul C. L., Ramarao P., Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods and Findings in Experimental and Clinical Pharmacology 2004 26 5 327 333 2-s2.0-3242663477 10.1358/mf.2004.26.5.831322 (Pubitemid 38954807)
34. O'Rourke C. M., Davis J. A., Saltiel A. R., Cornicelli J. A., Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus. Metabolism 1997 46 2 192 198 2-s2.0-0031055079 10.1016/S0026-0495(97)90301-2 (Pubitemid 27078766)
35. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 2-s2.0-0028139089 10.1038/372425a0 (Pubitemid 24365442)
36. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 1996 334 5 292 295 2-s2.0-13344295079 10.1056/NEJM199602013340503 (Pubitemid 26033933)
37. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M., Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 5223 543 546 2-s2.0-0029073613
38. Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhangs Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P. A., Friedman J. M., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1 11 1155 1161 2-s2.0-0028845877
39. Kim H. J., Kim S. K., Shim W. S., Lee J. H., Hur K. Y., Kang E. S., Ahn C. W., Lim S. K., Lee H. C., Cha B. S., Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2008 81 1 42 49 2-s2.0-44649123582 10.1016/j.diabres.2008.02.001
40. Chou F. S., Wang P. S., Kulp S., Pinzone J. J., Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Molecular Cancer Research 2007 5 6 523 530 2-s2.0-34250901928 10.1158/1541-7786.MCR-06- 0278 (Pubitemid 46985043)
41. Berthelier C., Kergoat M., Portha B., Lack of deterioration of insulin action with aging in the GK rat: a contrasted adaptation as compared with nondiabetic rats. Metabolism 1997 46 8 890 896 2-s2.0-0030855545 10.1016/S0026-0495(97)90075-5 (Pubitemid 27339912)
42. Movassat J., Bailbé D., Lubrano-Berthelier C., Picarel-Blanchot F., Bertin E., Mourot J., Portha B., Follow-up of GK rats during prediabetes highlights increased insulin action and fat deposition despite low insulin secretion. American Journal of Physiology-Endocrinology and Metabolism 2008 294 1 E168 E175 2-s2.0-38349039301 10.1152/ajpendo.00501.2007